The extent and nature of furosemide (F) binding to human albumin (HA) and to the plasma of 6 children with nephrotic syndrome were studied by equilibrium dialysis at 37° C and pH 7.4 with 14C-F. At a total concentration of 3.4 µ/ml (therapeutic range), the unbound fraction of F to 4 gm per 100 ml HA was 2.79 ± 0.35. The degree of binding was relatively constant from 1.8 to 36 µ/ml of F concentration. The percentage of unbound F doubled when total concentration of the drug was increased more than 130 times 0.8 to 245 µ/ml). F has two classes of binding sites (n1 = 1.42, k1 = 5.07 × 104 M−1; n2 = 3.4. k2 = 1.58 × 104 M−1); interaction with HA involves hydrophobic. ionic. and hydrogen forces. Acetylsalicylic acid (ASA). acetazolamide, diazoxide, phenylbutazone, sulfisoxazole (S), and tolbutamide (T) decreased F binding. Combinations of ASA, S, and T exerted a strong additive displacing effect. The binding of the F metabolite (4-chloro-5-sulfamoylanthranilic acid, CSA) was studied at 1.3 and 2.6 µ/ml. The unbound fraction was 5 times that of F. CSA did not influence F binding. Studies with plasma of 7 healthy adults showed that albumin is the only plasma protein responsible for F binding. The plasma albumin concentration range of the children with nephrotic syndrome was 0.6 to 2.1 gm per 100 ml. There was some correlation between albumin concentration and binding of F (2.8 to 9.6% unbound); this corresponded with findings with HA. Albumin concentrations lower than 2 gm per 100 ml seemed to influence the extent of the unbound fraction of F considerably.